Literature DB >> 7820711

Prognostic value of the immediate response to surfactant.

J Kuint1, B Reichman, L Neumann, E S Shinwell.   

Abstract

AIM: To evaluate the association between the immediate response to surfactant treatment and morbidity and mortality in infants with severe respiratory distress syndrome.
METHODS: The response to surfactant was defined as the difference in the arterial:alveolar (delta a:A) ratio before and one hour after the first surfactant dose. Measurements were obtained from 253 Israeli infants participating in the multi-centre Curosurf 4 trial of surfactant replacement therapy.
RESULTS: Delta a:A ratios ranged from -0.115 to 0.8 and were significantly related to both birth weight and gestational age. Among infants weighing 1001-1500 g mortality decreased from 40% among very bad responders to zero among good responders. The incidence of pneumothorax decreased with better response. Logistic regression analysis showed a hierarchy of predictive power for mortality: birth weight or gestational age; immediate response to surfactant; severity of initial disease.
CONCLUSION: The immediate response to surfactant treatment is a significant prognostic indicator for mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820711      PMCID: PMC1061119          DOI: 10.1136/fn.71.3.f170

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  11 in total

1.  Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.

Authors:  R H Phibbs; R A Ballard; J A Clements; D C Heilbron; C S Phibbs; M A Schlueter; S H Sniderman; W H Tooley; A Wakeley
Journal:  Pediatrics       Date:  1991-07       Impact factor: 7.124

2.  Surfactant substitution in ventilated very low birth weight infants: factors related to response types.

Authors:  H Segerer; P Stevens; B Schadow; R Maier; E Kattner; H Schwarz; T Curstedt; B Robertson; M Obladen
Journal:  Pediatr Res       Date:  1991-12       Impact factor: 3.756

3.  Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome.

Authors:  A Charon; W Taeusch; C Fitzgibbon; G B Smith; S T Treves; D S Phelps
Journal:  Pediatrics       Date:  1989-03       Impact factor: 7.124

4.  Artificial surfactant therapy in hyaline-membrane disease.

Authors:  T Fujiwara; H Maeta; S Chida; T Morita; Y Watabe; T Abe
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

5.  Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

Authors:  W Long; T Thompson; H Sundell; R Schumacher; F Volberg; R Guthrie
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

Review 6.  Impact of lung surfactant therapy on chronic lung diseases in premature infants.

Authors:  B B Hudak; E A Egan
Journal:  Clin Perinatol       Date:  1992-09       Impact factor: 3.430

7.  Prediction of outcome shortly after delivery for the very low birthweight (less than or equal to 1500 g) infant.

Authors:  C C Patterson; H L Halliday
Journal:  Paediatr Perinat Epidemiol       Date:  1988-07       Impact factor: 3.980

8.  Asphyxia and hyaline membrane disease in neonatal monkeys.

Authors:  J R Hessler; G Mantilla; B V Kirkpatrick; W H Donnelly; S Cassin; D V Eitzman
Journal:  Am J Perinatol       Date:  1985-04       Impact factor: 1.862

9.  Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Authors:  M Hallman; T A Merritt; A L Jarvenpaa; B Boynton; F Mannino; L Gluck; T Moore; D Edwards
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

10.  Surfactant therapy failure identifies infants at risk for pulmonary mortality.

Authors:  A Hamvas; T Devine; F S Cole
Journal:  Am J Dis Child       Date:  1993-06
View more
  2 in total

1.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

2.  Predictors for mortality.

Authors:  B Mitchell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.